Plasma kallikrein inhibitors
US-2024190892-A1 · Jun 13, 2024 · US
This page is not indexed by search engines while we improve data quality.
Xiao Dong patents
Xiao Dong holds 17 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 17 |
| Recent patents | 2 |
| First publication | Jan 6, 2015 |
| Latest publication | Jun 13, 2024 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Adenosine a2a and a2b receptor dual antagonists for immuno-oncology
US-2023322785-A1 · Oct 12, 2023 · US
Antidiabetic compounds
US-10059667-B2 · Aug 28, 2018 · US
Antidiabetic bicyclic compounds
US-2017217918-A1 · Aug 3, 2017 · US
Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties
US-9676780-B2 · Jun 13, 2017 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Plasma kallikrein inhibitors
US-2024190892-A1 · Jun 13, 2024 · US
Adenosine a2a and a2b receptor dual antagonists for immuno-oncology
US-2023322785-A1 · Oct 12, 2023 · US
Antidiabetic compounds
US-10059667-B2 · Aug 28, 2018 · US
Antidiabetic bicyclic compounds
US-2017217918-A1 · Aug 3, 2017 · US
Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties
US-9676780-B2 · Jun 13, 2017 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 17 |
| Chemistry & Metallurgy | 17 |
| Cross-Sectional Technologies | 1 |